Drug Interactions and Incompatibilities

Drug interactions and incompatibilities concern the ways in which one medicine can alter the effect or safety of another, or be physically incompatible with it, when given together. Because patients - especially those with multiple conditions - frequently take several drugs at once, recognising how these agents influence each other is central to choosing and combining medicines safely.

Definition

A drug interaction is a change in the effect or disposition of one drug caused by another drug, food, or a disease state; an incompatibility is a physicochemical reaction - such as precipitation or degradation - that occurs when drugs are combined outside the body, for example in the same infusion.

Scope

The topic covers pharmacokinetic interactions that change drug exposure, pharmacodynamic interactions that change drug effect, drug-disease interactions in which a condition makes a drug hazardous, and physicochemical incompatibilities that occur when drugs are mixed or co-administered. It is a reference topic explaining the mechanisms and significance of interactions and does not provide management instructions for any patient.

Core questions

• How does one drug change the exposure to another (pharmacokinetic interactions)?
• How do drugs combine to amplify or oppose each other's effects (pharmacodynamic interactions)?
• When does a disease make an otherwise suitable drug hazardous (drug-disease interactions)?
• What are incompatibilities, and how do they differ from pharmacological interactions?
• How are clinically important interactions distinguished from the many that are trivial?

Key concepts

• Pharmacokinetic interactions
• Enzyme induction and inhibition
• Transporter-mediated interactions
• Pharmacodynamic interactions (additive, synergistic, antagonistic)
• Drug-disease interactions
• Physicochemical incompatibility
• Clinical significance and risk stratification

Mechanisms

Interactions act through several distinct routes. Pharmacokinetic interactions change how much drug reaches its site of action: one drug may induce or inhibit the metabolising enzymes - notably cytochrome P450 - or transporters that handle another, raising or lowering its exposure. Pharmacodynamic interactions occur when drugs act on the same or related systems, producing additive, synergistic, or antagonistic effects without necessarily changing concentrations; the serotonin syndrome from combining serotonergic agents is one example. Drug-disease interactions arise when a coexisting condition turns an ordinarily acceptable drug into a hazard. Incompatibilities are different in kind: they are physical or chemical reactions - precipitation, inactivation, degradation - that occur when drugs are mixed before reaching the patient, such as in a shared intravenous line, and concern formulation rather than physiology.

Clinical relevance

Anticipating interactions and incompatibilities is integral to drug selection, combination, and preparation, and is a core safety function of clinical pharmacy. As a reference topic this entry explains the mechanisms and clinical significance of interactions; it describes how interactions are reasoned about and is not a source of management, substitution, or dosing advice for any individual.

Epidemiology

Potential interactions are very common in patients taking multiple drugs, but only a minority are clinically important; harm from interactions contributes to the broader burden of adverse drug reactions, which account for a measurable proportion of hospital admissions. The challenge is separating the clinically significant from the trivial, a task complicated when patients have several conditions whose guidelines each recommend interacting drugs.

Evidence & guidelines

Systematic examination of national clinical guidelines shows that recommendations for single diseases routinely involve drugs that interact with other commonly co-prescribed medicines or with comorbid conditions, exposing a gap between single-disease guidance and the reality of multimorbidity. Interaction knowledge is curated in reference compendia and decision-support systems rather than in a single guideline.

History

As the number of available medicines and the prevalence of multidrug therapy grew through the twentieth century, drug interactions became a recognised and systematically catalogued hazard. The elucidation of cytochrome P450 metabolism and of transporter systems gave a mechanistic basis for many pharmacokinetic interactions, while attention to multimorbidity later highlighted drug-disease interactions and the limits of single-disease guidelines.

Debates

Single-disease guidelines versus multimorbidity

Clinical guidelines are largely written for single conditions, yet many patients have several; systematic analysis shows this routinely generates potential drug-drug and drug-disease interactions, raising the question of how guidance should account for comorbidity and co-prescribing.

Seminal works

• wilkinson-2005
• dumbreck-2015

Frequently asked questions

How does an interaction differ from an incompatibility?

An interaction is a pharmacological effect of one drug on another's action or disposition inside the body; an incompatibility is a physical or chemical reaction that occurs when drugs are mixed outside the body, such as precipitation in a shared infusion line.

Are all drug interactions dangerous?

No. Many potential interactions have little or no clinical consequence; only a subset meaningfully changes effect or safety. A central task is distinguishing the clinically important interactions from the many trivial ones.